Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Show Therapeutic Classes
QR Code Add Formweb to your mobile device
Android iOS
Medications not yet evaluated by P&T are considered NON-FORMULARY. Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step!
Please be sure to document all clinical activities daily.
Approved Hospital Formulary
Suggestions or Corrections? Above and Beyond Nominations Formulary Request
Search results for:

raloxifene

raloxifene
  • Formulary
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Evista TABLET, ORAL 60 mg      
VIEW MORE Estrogen Agonists-Antagonists
Last updated: Feb. 3, 2025
Rhazdrugs raloxifene
  • Black Box Warning: Risk of VTE and death from stroke
  • HAZ-MED: Table 2H
  • Hormonal Therapy: This drug is a hormonal therapy in used in oncologic conditions. This drug may be resumed by a hospitalist or non-oncology healthcare provider without contacting an oncology pharmacy specialist or consulting an oncologist.






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2026 Rpharmy, LLC ­ All Rights Reserved